Lumida
/EWTX
⌘K
Edgewise Therapeutics Inc

Edgewise Therapeutics Inc

EWTX
$44.40USD+3.50%+1.50 today

MARKET CAP

4.8B

P/E (TTM)

FWD P/E

39.5x

DAY RANGE

$43 – $45

52W RANGE

$14
$48

AI Summary

Stalk
StalkMedium

While the medium-term structure remains bullish with a Stage 2 advance and a recent momentum breakout above consolidation, short-term exhaustion at the highs and extended price above EMAs suggest timing is poor. Execution is best deferred to a pullback into the rising EMAs and 50 SMA for an asymmetric entry.

  • Sale of muscular dystrophy unit raised $1.55B capital
  • Pro forma cash balance ~$2.01B bolsters R&D funding
  • Low profitability score highlights ongoing earnings struggles
Full analysis →
Insider Trades49 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 12, 2026SellEWTXJohn R MooreGeneral Counsel5,016$43.82$4.8B-8.26%+224.44%$219.8K-2.36%Sell Now
Aug 12, 2026SellEWTXBehrad DerakhshanChief Business Officer5,100$43.81$4.8B-8.26%+224.44%$223.4K-1.57%Sell Now
Aug 12, 2026SellEWTXAlan J RussellChief Scientific Officer5,901$43.73$4.8B-8.26%+224.44%$258.0K-2.53%Sell Now
Aug 12, 2026SellEWTXJoanne M. DonovanCMO9,441$43.71$4.8B-8.26%+224.44%$412.7K-4.73%Sell Now
Aug 12, 2026SellEWTXKevin KochPresident and CEO17,971$43.68$4.8B-8.26%+224.44%$785.0K-3.06%Sell Now
Jul 1, 2026SellEWTXAlan J RussellChief Scientific Officer400,000$19.88$4.8B-8.26%+224.44%$8.0M+0.00%Sell Now
May 4, 2026SellEWTXJoanne M. DonovanCMO105,230$23.24$4.8B-8.26%+224.44%$2.4M-3.65%Sell Now
Apr 1, 2026SellEWTXJoanne M. DonovanCMO57,324$19.70$4.8B-8.26%+224.44%$1.1M+0.00%10b5-1Sell Now
Mar 31, 2026SellEWTXJoanne M. DonovanCMO42,676$19.60$4.8B-8.26%+224.44%$836.4K+0.00%10b5-1Sell Now
Mar 27, 2026SellEWTXJoanne M. DonovanCMO16,358$30.98$4.8B-8.26%+224.44%$506.7K-38.68%Sell Now
Nov 12, 2025SellEWTXAlan J RussellChief Scientific Officer200,000$10.65$4.8B-8.26%+224.44%$2.1M+0.00%Sell Now
Aug 26, 2025SellEWTXAlan J RussellChief Scientific Officer200,000$7.39$4.8B-8.26%+224.44%$1.5M+0.00%Sell Now
Aug 12, 2025SellEWTXR Michael CarruthersChief Financial Officer1,428$13.39$4.8B-8.26%+224.44%$19.1K-0.49%Sell Now
Aug 12, 2025SellEWTXAlan J RussellChief Scientific Officer1,907$13.39$4.8B-8.26%+224.44%$25.5K-0.80%Sell Now
Aug 12, 2025SellEWTXJohn R MooreGeneral Counsel2,098$13.39$4.8B-8.26%+224.44%$28.1K-0.96%Sell Now
Aug 12, 2025SellEWTXBehrad DerakhshanChief Business Officer2,491$13.39$4.8B-8.26%+224.44%$33.4K-0.98%Sell Now
Aug 12, 2025SellEWTXJoanne M. DonovanCMO2,862$13.39$4.8B-8.26%+224.44%$38.3K-1.18%Sell Now
Aug 12, 2025SellEWTXKevin KochPresident and CEO7,972$13.39$4.8B-8.26%+224.44%$106.8K-1.13%Sell Now
May 2, 2025SellEWTXR Michael CarruthersChief Financial Officer1,314$16.45$4.8B-8.26%+224.44%$21.6K-1.60%Sell Now
May 2, 2025SellEWTXAlan J RussellChief Scientific Officer1,551$16.45$4.8B-8.26%+224.44%$25.5K-7.73%Sell Now
May 2, 2025SellEWTXBehrad DerakhshanChief Business Officer1,691$16.45$4.8B-8.26%+224.44%$27.8K-7.67%Sell Now
May 2, 2025SellEWTXJohn R MooreGeneral Counsel1,930$16.45$4.8B-8.26%+224.44%$31.8K-22.81%Sell Now
May 2, 2025SellEWTXKevin KochPresident and CEO4,276$16.45$4.8B-8.26%+224.44%$70.4K-17.18%Sell Now
May 2, 2025SellEWTXJoanne M. DonovanCMO5,187$16.45$4.8B-8.26%+224.44%$85.3K-19.37%Sell Now
Mar 7, 2025SellEWTXKevin KochPresident and CEO200$15.09$4.8B-8.26%+224.44%$3.0K+0.00%10b5-1Sell Now
Mar 7, 2025SellEWTXAlan J RussellChief Scientific Officer400$15.10$4.8B-8.26%+224.44%$6.0K+0.00%10b5-1Sell Now
Feb 5, 2025SellEWTXAlan J RussellChief Scientific Officer18,430$15.11$4.8B-8.26%+224.44%$278.4K+0.00%10b5-1Sell Now
Feb 5, 2025SellEWTXKevin KochPresident and CEO19,072$15.76$4.8B-8.26%+224.44%$300.7K+0.00%10b5-1Sell Now
Feb 5, 2025SellEWTXBehrad DerakhshanChief Business Officer20,000$15.98$4.8B-8.26%+224.44%$319.6K+0.00%10b5-1Sell Now
Jan 28, 2025SellEWTXJoanne M. DonovanCMO50,000$17.35$4.8B-8.26%+224.44%$867.7K+0.00%10b5-1Sell Now
Dec 30, 2024SellEWTXAlan J RussellChief Scientific Officer200,000$13.78$4.8B-8.26%+224.44%$2.8M+0.00%10b5-1Sell Now
Dec 24, 2024SellEWTXMarc SemigranChief Development Officer59,418$19.31$4.8B-8.26%+224.44%$1.1M+0.00%10b5-1Sell Now
Oct 11, 2024BuyEWTXR Michael CarruthersChief Financial Officer70,000$0.71$4.8B-8.26%+224.44%$49.7K+52.23%Sell Now
Sep 20, 2024SellEWTXJoanne M. DonovanCMO7,162$28.29$4.8B-8.26%+224.44%$202.6K-33.00%Sell Now
Sep 20, 2024SellEWTXBehrad DerakhshanChief Business Officer84,136$15.48$4.8B-8.26%+224.44%$1.3M+0.00%Sell Now
Sep 20, 2024SellEWTXJohn R MooreGeneral Counsel141,844$14.43$4.8B-8.26%+224.44%$2.0M+0.00%Sell Now
Sep 20, 2024SellEWTXAlan J RussellChief Scientific Officer150,000$14.22$4.8B-8.26%+224.44%$2.1M+0.00%Sell Now
Sep 20, 2024SellEWTXR Michael CarruthersChief Financial Officer221,160$17.00$4.8B-8.26%+224.44%$3.8M-9.99%Sell Now
May 2, 2024SellEWTXAlan J RussellChief Scientific Officer1,576$18.91$4.8B-8.26%+224.44%$29.8K-11.24%Sell Now
May 2, 2024SellEWTXBehrad DerakhshanChief Business Officer1,718$18.91$4.8B-8.26%+224.44%$32.5K-8.44%Sell Now
May 2, 2024SellEWTXJohn R MooreGeneral Counsel1,956$18.91$4.8B-8.26%+224.44%$37.0K-18.78%Sell Now
May 2, 2024SellEWTXR Michael CarruthersChief Financial Officer2,157$18.91$4.8B-8.26%+224.44%$40.8K-5.06%Sell Now
May 2, 2024SellEWTXKevin KochPresident and CEO3,152$18.91$4.8B-8.26%+224.44%$59.6K-11.24%Sell Now
May 2, 2024SellEWTXJoanne M. DonovanCMO3,682$18.91$4.8B-8.26%+224.44%$69.6K-10.83%Sell Now
Feb 7, 2024SellEWTXBehrad DerakhshanChief Business Officer20,000$10.98$4.8B-8.26%+224.44%$219.6K+0.00%10b5-1Sell Now
Feb 7, 2024SellEWTXJohn R MooreGeneral Counsel59,670$10.97$4.8B-8.26%+224.44%$654.4K+0.00%10b5-1Sell Now
Jan 23, 2024SellEWTXR Michael CarruthersChief Financial Officer180,000$8.85$4.8B-8.26%+224.44%$1.6M+0.00%10b5-1Sell Now
Dec 27, 2023SellEWTXJohn R MooreGeneral Counsel8,497$10.50$4.8B-8.26%+224.44%$89.2K-100.00%10b5-1Sell Now
Dec 26, 2023SellEWTXAlan J RussellChief Scientific Officer172,585$9.33$4.8B-8.26%+224.44%$1.6M-97.95%Sell Now